In planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system

被引:17
作者
Fujiyama, Kazuhito
Saejung, Wanida
Yanagihara, Itaru
Nakado, Junko
Misaki, Ryo
Honda, Takeshi
Watanabe, Yuichiro
Seki, Tatsuji
机构
[1] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan
[2] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Infect Dis, Izumi Ku, Osaka 5941101, Japan
[3] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Suita, Osaka 5650871, Japan
[4] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan
关键词
poliovirus; tobacco mosaic virus; Nicotiana tahacum cv. Samsun;
D O I
10.1263/jbb.101.398
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The tobacco mosaic virus (TMV) provides an attractive means of producing foreign peptides in plants. In this study, a TMV-based vector was designed such that a fragment encoding 15 amino acids of the poliovirus peptide (PVP) derived from the viral capsid proteins VP3 and VP1 of poliovirus type I Sabin was inserted downstream of the six-base 3' context nucleotide sequence of the TMV coat protein (CP) gene. This design allowed readthrough at the amber stop codon, thereby producing the chimeric TMV particle with both intact CP and CP-fusion protein (CP-PVP) in Nicotiana tabacum cv. Samsun infected with the TMV vector. The TMVCP-PVP virus particle induced antibodies against PVP as well as TMVCP in mice after intraperitoneal immunization. These data illustrate the potential of the readthrough translation system with TMVCP for antigen presentation and vaccine production.
引用
收藏
页码:398 / 402
页数:5
相关论文
共 31 条
[1]  
Andrus JK, 2001, AM J PUBLIC HEALTH, V91, P146, DOI 10.2105/AJPH.91.1.146
[2]   CHARACTERIZATION AND INVITRO TRANSLATION OF RNAS FROM LESS-THAN-FULL-LENGTH, VIRUS-RELATED, NUCLEOPROTEIN RODS PRESENT IN TOBACCO MOSAIC-VIRUS PREPARATIONS [J].
BEACHY, RN ;
ZAITLIN, M .
VIROLOGY, 1977, 81 (01) :160-169
[3]   Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice [J].
Buttinelli, G ;
Ruggeri, FM ;
Marturano, J ;
Novello, F ;
Donati, V ;
Fiore, L .
VIROLOGY, 2001, 281 (02) :265-271
[4]   Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants [J].
Daniell, H ;
Streatfield, SJ ;
Wycoff, K .
TRENDS IN PLANT SCIENCE, 2001, 6 (05) :219-226
[5]   The global value of vaccination [J].
Ehreth, J .
VACCINE, 2003, 21 (7-8) :596-600
[6]   STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE-3 POLIOVIRUS [J].
FILMAN, DJ ;
SYED, R ;
CHOW, M ;
MACADAM, AJ ;
MINOR, PD ;
HOGLE, JM .
EMBO JOURNAL, 1989, 8 (05) :1567-1579
[7]   Molecular farming of pharmaceutical proteins [J].
Fischer, R ;
Emans, N .
TRANSGENIC RESEARCH, 2000, 9 (4-5) :279-299
[8]  
Fischer R, 2000, J BIOL REG HOMEOS AG, V14, P83
[9]   Molecular farming of recombinant antibodies in plants [J].
Fischer, R ;
Liao, YC ;
Hoffmann, K ;
Schillberg, S ;
Emans, N .
BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) :825-839
[10]   PLANT-VIRUS EXPRESSING HYBRID COAT PROTEIN WITH ADDED MURINE EPITOPE ELICITS AUTOANTIBODY RESPONSE [J].
FITCHEN, J ;
BEACHY, RN ;
HEIN, MB .
VACCINE, 1995, 13 (12) :1051-1057